# Achaogen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/achaogen

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: www.achaogen.com
- Total disclosed funding: $127M
- Latest round: Series D (Nov 21, 2013)
- Investors on record: 8

## About

Founded in 2004 and based in San Francisco, US, Achaogen, Inc. is a biopharmaceutical company that is focused on the discovery, development, and commercialization of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.

## Funding rounds

- Series D, Nov 21, 2013, $10M — Alta Partners, ARCH Venture Partners, Domain Associates, Versant Ventures, 5AM Ventures
- Series D, Mar 6, 2013, $19M — Alta Partners, ARCH Venture Partners, Domain Associates, Frazier Healthcare Partners, Versant Ventures, Venrock
- Series C, Apr 7, 2010, $56M — Alta Partners, ARCH Venture Partners, Domain Associates, Frazier Healthcare Partners, Versant Ventures, Wellcome Trust, Venrock, 5AM Ventures
- Series B, Oct 10, 2006, $26M — ARCH Venture Partners, Domain Associates, Versant Ventures, Venrock, 5AM Ventures
- Series A, Aug 1, 2004, $16M — ARCH Venture Partners, Versant Ventures, Venrock, 5AM Ventures

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B, Series C, Series D
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B, Series C, Series D
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A, Series B, Series C, Series D
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A, Series B, Series C, Series D
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C, Series D
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C, Series D
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series C, Series D
- Wellcome Trust — Series C